COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,158 Articles (22,703 medRxiv, 8,455 bioRxiv)

Most recent first Previous |  Page 233: Articles 2321-2330  | Next

Clinical characterization of new-onset chronic musculoskeletal pain in Long COVID: a cross-sectional study
Khoja, O., Silva-Passadouro, B., Cristescu, E., McEwan, K., Doherty, D., OConnell, F., Ponchel, F., Mulvey, M., Astill, S., Tan, A. L., Sivan, M.
10.1101/2024.03.09.24304024 — Posted: 2024-03-15
Seroprevalence and risk factors for SARS-CoV-2 infection in middle-sized cities of Burkina Faso: A descriptive cross-sectional study
SANA, A., DJEMAI, E., DE VREYER, P., THIVILLON, T., BADOLO, H., BERTHE, A., KANIA, D.
10.1101/2024.03.13.24304208 — Posted: 2024-03-15
Characterization of Maternal Mortality and Severe Maternal Morbidity before and during Covid-19: an analysis for the Dominican Republic
Santos Mercedes, K. D., Zanatta Coutinho, R.
10.1101/2024.03.11.24304148 — Posted: 2024-03-15
COVID-19 mortality in the Philippines: a province-level analysis, 2020-2023
Celeste, J. N., Sevilleja, J. E. A. D., Bongolan, V. P., Rivera, R. L. K., Caoili, S. E., de Castro, R.
10.1101/2024.03.14.24304321 — Posted: 2024-03-15
Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity
Luo, X., McAndrews, K. M., Arian, K. A., Morse, S. J., Boeker, V., Kumbhar, S. V., Hu, Y., Mahadevan, K. K., Church, K. A., Chitta, S., Ryujin, N. T., Hensel, J., Dai, J., Dowlatshahi, D. P., Sugimoto, H., Kirtley, M. L., LeBleu, V. S., Shalapour, S., Simmons, J. H., Kalluri, R.
10.1101/2024.03.14.585062 — Posted: 2024-03-15
Protein-based cell population discovery and annotation for CITE-seq data identifies cellular phenotypes associated with critical COVID-19 severity
Allen, D., Weaver, M., Prokopchuk, S., Lekschas, F., Jiang, M., Finak, G., Greene, E., McDavid, A.
10.1101/2024.03.14.584720 — Posted: 2024-03-15
Differential Patterns of Cross-Protection against Antigenically Distinct Variants in Small Animal Models of SARS-CoV-2 Infection
Selvaraj, P., Stauft, C. B., Liu, S., Sangare, K., Wang, T. T.
10.1101/2024.03.14.584985 — Posted: 2024-03-15
de Novo Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination
Le Bihan, T., Nunez de Villavicencio Diaz, T., Reitzel, C., Lange, V., Park, M., Beadle, E. M., Wu, L., Jovic, M., Dubois, R. M., Couzens, A. L., Duan, J., Han, X., Liu, Q., Ma, B.
10.1101/2024.03.14.583523 — Posted: 2024-03-15
Functional assessment of cell entry and receptor use for merbecoviruses
Letko, M. C.
10.1101/2024.03.13.584892 — Posted: 2024-03-14
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Chao, C. W., Sprouse, K. R., Miranda, M. C., Catanzaro, N. J., Hubbard, M. L., Addetia, A., Stewart, C., Brown, J. T., Dosey, A., Valdez, A., Ravichandran, R., Hendricks, G. G., Ahlrichs, M., Dobbins, C., Hand, A., Treichel, C., Willoughby, I., Walls, A. C., McGuire, A. T., Leaf, E. M., Baric, R. S., Schaefer, A., Veesler, D., King, N. P.
10.1101/2024.03.13.584735 — Posted: 2024-03-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).